- Exchange: NASDAQ CM
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Therapeutics
Threshold Pharmaceuticals Inc
Add to PortfolioTHLD:US
6.9400 USD 0.1400 2.06%As of 20:10:00 ET on 05/29/2012.
Snapshot for Threshold Pharmaceuticals Inc (THLD)
| Open: | 6.8100 | Day's Range: | 6.8100 - 7.1000 | Volume: | 1,263,825 | Bid: | 6.9400 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 6.8000 | 52wk Range: | 1.1800 - 9.0700 | 1-Yr Rtn: | +305.85% | Ask: | 6.9500 |
Key Statistics for THLD
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E (12/2012) | - |
| Earnings Per Share (USD) (ttm) | -2.6500 |
| Est. EPS (USD) (12/2012) | -2.4030 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 378.23 |
| Shares Outstanding (M) | 54.50 |
| Enterprise Value (M USD) (ttm) | 328.50 |
| Enterprise Value/EBITDA (ttm) | - |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | 1,106.9708 |
| Dividend Indicated Gross Yield | 0.0000 |
| Next Earnings Announcement | 08/03/2012 |
More THLD Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for THLD
- Operating
- Investing
- Financing (M/USD)
Company Profile & Key Executives for THLD
Threshold Pharmaceuticals Inc. is a biotechnology company focused on the discovery, development and commercialization of small molecule therapeutics based on Metabolic Targeting, an approach that targets fundamental differences in metabolism between normal and certain diseased cells.
| Harold E Selick "Barry"Chief Executive Officer | Tillman PearceChief Medical Officer |
| Mark G MatteucciSenior VP:Discovery Research | Robert L Simon "Bob"Senior VP:Regulatory Affairs |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page